Do analysts prefer CRVL or CHE?

Chemed has a consensus target price of $530.75, suggesting a potential downside of 0.70%. Given Chemed's stronger consensus rating and higher probable upside, analysts clearly believe Chemed is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Chemed 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17

Which has preferable earnings and valuation, CRVL or CHE?

Chemed has higher revenue and earnings than CorVel. Chemed is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CorVel $958.53M 3.19 $110.34M $2.14 28.04 Chemed $2.60B 2.73 $265.24M $19.91 26.85

Is CRVL or CHE more profitable?

CorVel has a net margin of 11.51% compared to Chemed's net margin of 10.60%. Chemed's return on equity of 31.77% beat CorVel's return on equity. Company Net Margins Return on Equity Return on Assets CorVel 11.51% 29.92% 17.68% Chemed 10.60% 31.77% 18.90%

Does the media prefer CRVL or CHE?

In the previous week, Chemed had 18 more articles in the media than CorVel. MarketBeat recorded 25 mentions for Chemed and 7 mentions for CorVel. CorVel's average media sentiment score of 1.33 beat Chemed's score of 0.99 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemed 14 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CRVL or MD?

Pediatrix Medical Group has a consensus target price of $23.33, suggesting a potential downside of 11.41%. Given Pediatrix Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe Pediatrix Medical Group is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Pediatrix Medical Group 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17

Does the media refer more to CRVL or MD?

In the previous week, CorVel had 3 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 7 mentions for CorVel and 4 mentions for Pediatrix Medical Group. CorVel's average media sentiment score of 1.33 beat Pediatrix Medical Group's score of 1.14 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pediatrix Medical Group 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CRVL or AMN?

AMN Healthcare Services has a consensus price target of $29.00, suggesting a potential downside of 14.66%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, analysts plainly believe AMN Healthcare Services is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 AMN Healthcare Services 2 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.22

Does the media prefer CRVL or AMN?

In the previous week, AMN Healthcare Services had 1 more articles in the media than CorVel. MarketBeat recorded 8 mentions for AMN Healthcare Services and 7 mentions for CorVel. CorVel's average media sentiment score of 1.33 beat AMN Healthcare Services' score of 1.01 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AMN Healthcare Services 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CCRN or CRVL?

Cross Country Healthcare currently has a consensus price target of $12.05, indicating a potential downside of 9.06%. Given Cross Country Healthcare's higher probable upside, equities research analysts clearly believe Cross Country Healthcare is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cross Country Healthcare 1 Sell rating(s) 9 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.90 CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to CCRN or CRVL?

In the previous week, CorVel had 4 more articles in the media than Cross Country Healthcare. MarketBeat recorded 7 mentions for CorVel and 3 mentions for Cross Country Healthcare. CorVel's average media sentiment score of 1.33 beat Cross Country Healthcare's score of 0.89 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer LH or CRVL?

Labcorp currently has a consensus price target of $321.80, suggesting a potential upside of 3.40%. Given Labcorp's stronger consensus rating and higher probable upside, equities research analysts clearly believe Labcorp is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Labcorp 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.75 CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, LH or CRVL?

Labcorp has higher revenue and earnings than CorVel. Labcorp is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Labcorp $13.95B 1.83 $876.50M $11.29 27.57 CorVel $958.53M 3.19 $110.34M $2.14 28.04

Is LH or CRVL more profitable?

CorVel has a net margin of 11.51% compared to Labcorp's net margin of 6.66%. CorVel's return on equity of 29.92% beat Labcorp's return on equity. Company Net Margins Return on Equity Return on Assets Labcorp 6.66% 16.29% 7.62% CorVel 11.51% 29.92% 17.68%

Does the media refer more to LH or CRVL?

In the previous week, Labcorp had 20 more articles in the media than CorVel. MarketBeat recorded 27 mentions for Labcorp and 7 mentions for CorVel. CorVel's average media sentiment score of 1.33 beat Labcorp's score of 0.89 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 13 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

CorVel (CRVL) Competitors

$60.01 +0.52 (+0.87%)

As of 01:33 PM Eastern

Compare

CRVL vs. CHE, MD, AMN, CCRN, and LH

Should you buy CorVel stock or one of its competitors? MarketBeat compares CorVel with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CorVel include Chemed (CHE), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), and Labcorp (LH).

How does CorVel compare to Chemed?

CorVel (NASDAQ:CRVL) and Chemed (NYSE:CHE) are both mid-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

51.4% of CorVel shares are held by institutional investors. Comparatively, 95.8% of Chemed shares are held by institutional investors. 39.7% of CorVel shares are held by company insiders. Comparatively, 3.3% of Chemed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

CorVel has a beta of 0.98, indicating that its share price is 2% less volatile than the broader market. Comparatively, Chemed has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market.

In the previous week, Chemed had 18 more articles in the media than CorVel. MarketBeat recorded 25 mentions for Chemed and 7 mentions for CorVel. CorVel's average media sentiment score of 1.33 beat Chemed's score of 0.99 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemed	14 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Chemed has higher revenue and earnings than CorVel. Chemed is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.19	$110.34M	$2.14	28.04
Chemed	$2.60B	2.73	$265.24M	$19.91	26.85

CorVel has a net margin of 11.51% compared to Chemed's net margin of 10.60%. Chemed's return on equity of 31.77% beat CorVel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.51%	29.92%	17.68%
Chemed	10.60%	31.77%	18.90%

Chemed has a consensus target price of $530.75, suggesting a potential downside of 0.70%. Given Chemed's stronger consensus rating and higher probable upside, analysts clearly believe Chemed is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Summary

Chemed beats CorVel on 10 of the 16 factors compared between the two stocks.

How does CorVel compare to Pediatrix Medical Group?

CorVel (NASDAQ:CRVL) and Pediatrix Medical Group (NYSE:MD) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Pediatrix Medical Group has a consensus target price of $23.33, suggesting a potential downside of 11.41%. Given Pediatrix Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe Pediatrix Medical Group is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Pediatrix Medical Group	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

CorVel has a net margin of 11.51% compared to Pediatrix Medical Group's net margin of 9.02%. CorVel's return on equity of 29.92% beat Pediatrix Medical Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.51%	29.92%	17.68%
Pediatrix Medical Group	9.02%	19.94%	8.02%

51.4% of CorVel shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 39.7% of CorVel shares are held by company insiders. Comparatively, 1.8% of Pediatrix Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Pediatrix Medical Group has higher revenue and earnings than CorVel. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.19	$110.34M	$2.14	28.04
Pediatrix Medical Group	$1.91B	1.13	$165.39M	$2.06	12.79

In the previous week, CorVel had 3 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 7 mentions for CorVel and 4 mentions for Pediatrix Medical Group. CorVel's average media sentiment score of 1.33 beat Pediatrix Medical Group's score of 1.14 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pediatrix Medical Group	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CorVel has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market. Comparatively, Pediatrix Medical Group has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market.

Summary

CorVel beats Pediatrix Medical Group on 10 of the 16 factors compared between the two stocks.

How does CorVel compare to AMN Healthcare Services?

CorVel (NASDAQ:CRVL) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

CorVel has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.19	$110.34M	$2.14	28.04
AMN Healthcare Services	$2.73B	0.48	-$95.70M	-$0.87	N/A

In the previous week, AMN Healthcare Services had 1 more articles in the media than CorVel. MarketBeat recorded 8 mentions for AMN Healthcare Services and 7 mentions for CorVel. CorVel's average media sentiment score of 1.33 beat AMN Healthcare Services' score of 1.01 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AMN Healthcare Services	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AMN Healthcare Services has a consensus price target of $29.00, suggesting a potential downside of 14.66%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, analysts plainly believe AMN Healthcare Services is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

CorVel has a beta of 0.98, indicating that its share price is 2% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.41, indicating that its share price is 59% less volatile than the broader market.

CorVel has a net margin of 11.51% compared to AMN Healthcare Services' net margin of -0.95%. CorVel's return on equity of 29.92% beat AMN Healthcare Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.51%	29.92%	17.68%
AMN Healthcare Services	-0.95%	18.01%	5.19%

51.4% of CorVel shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 39.7% of CorVel shares are held by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

CorVel beats AMN Healthcare Services on 10 of the 16 factors compared between the two stocks.

How does CorVel compare to Cross Country Healthcare?

Cross Country Healthcare (NASDAQ:CCRN) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and media sentiment.

CorVel has a net margin of 11.51% compared to Cross Country Healthcare's net margin of -9.84%. CorVel's return on equity of 29.92% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
CorVel	11.51%	29.92%	17.68%

In the previous week, CorVel had 4 more articles in the media than Cross Country Healthcare. MarketBeat recorded 7 mentions for CorVel and 3 mentions for Cross Country Healthcare. CorVel's average media sentiment score of 1.33 beat Cross Country Healthcare's score of 0.89 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cross Country Healthcare currently has a consensus price target of $12.05, indicating a potential downside of 9.06%. Given Cross Country Healthcare's higher probable upside, equities research analysts clearly believe Cross Country Healthcare is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cross Country Healthcare has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market. Comparatively, CorVel has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market.

CorVel has lower revenue, but higher earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.00B	0.43	-$94.85M	-$3.05	N/A
CorVel	$958.53M	3.19	$110.34M	$2.14	28.04

96.0% of Cross Country Healthcare shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 6.3% of Cross Country Healthcare shares are owned by company insiders. Comparatively, 39.7% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

CorVel beats Cross Country Healthcare on 12 of the 15 factors compared between the two stocks.

How does CorVel compare to Labcorp?

Labcorp (NYSE:LH) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations.

CorVel has a net margin of 11.51% compared to Labcorp's net margin of 6.66%. CorVel's return on equity of 29.92% beat Labcorp's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Labcorp	6.66%	16.29%	7.62%
CorVel	11.51%	29.92%	17.68%

Labcorp currently has a consensus price target of $321.80, suggesting a potential upside of 3.40%. Given Labcorp's stronger consensus rating and higher probable upside, equities research analysts clearly believe Labcorp is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

95.9% of Labcorp shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 0.8% of Labcorp shares are owned by company insiders. Comparatively, 39.7% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Labcorp had 20 more articles in the media than CorVel. MarketBeat recorded 27 mentions for Labcorp and 7 mentions for CorVel. CorVel's average media sentiment score of 1.33 beat Labcorp's score of 0.89 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Labcorp	13 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Labcorp has higher revenue and earnings than CorVel. Labcorp is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$13.95B	1.83	$876.50M	$11.29	27.57
CorVel	$958.53M	3.19	$110.34M	$2.14	28.04

Labcorp has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market. Comparatively, CorVel has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market.

Summary

Labcorp and CorVel tied by winning 8 of the 16 factors compared between the two stocks.

Get CorVel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRVL vs. The Competition

Export

Metric	CorVel	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.06B	$106.30M	$163.78M	$12.38B
Dividend Yield	N/A	N/A	N/A	10.11%
P/E Ratio	28.04	N/A	8.30	23.69
Price / Sales	3.19	1.60	106.64	78.17
Price / Cash	22.41	N/A	10.10	58.30
Price / Book	7.78	5.71	3.61	5.84
Net Income	$110.34M	-$19.95M	-$24.08M	$336.37M
7 Day Performance	0.25%	-5.98%	0.72%	-0.05%
1 Month Performance	-4.01%	-3.93%	-2.98%	-5.25%
1 Year Performance	-32.27%	-39.48%	-16.93%	17.48%

CorVel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRVL CorVel	1.7069 of 5 stars	$60.01 +0.9%	N/A	-32.9%	$3.06B	$958.53M	28.04	5,239	Positive News Upcoming Earnings
CHE Chemed	3.8413 of 5 stars	$500.74 -2.5%	$480.25 -4.1%	+28.5%	$6.64B	$2.53B	27.29	15,811	Earnings Report Analyst Forecast
MD Pediatrix Medical Group	1.7653 of 5 stars	$25.91 +0.8%	$23.33 -9.9%	+114.2%	$2.13B	$1.91B	12.58	4,315	Upcoming Earnings
AMN AMN Healthcare Services	1.9782 of 5 stars	$34.25 +1.5%	$27.00 -21.2%	+87.5%	$1.33B	$2.73B	N/A	2,664	News Coverage Positive News Upcoming Earnings
CCRN Cross Country Healthcare	2.5297 of 5 stars	$13.25 flat	$12.05 -9.1%	N/A	$428.11M	$1.05B	N/A	6,784	Upcoming Earnings High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRVL) was last updated on 7/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CorVel (CRVL) Competitors

CRVL vs. CHE, MD, AMN, CCRN, and LH

How does CorVel compare to Chemed?

Summary

How does CorVel compare to Pediatrix Medical Group?

Summary

How does CorVel compare to AMN Healthcare Services?

Summary

How does CorVel compare to Cross Country Healthcare?

Summary

How does CorVel compare to Labcorp?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRVL vs. The Competition

CorVel Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CorVel (CRVL) Competitors

CRVL vs. CHE, MD, AMN, CCRN, and LH

How does CorVel compare to Chemed?

Do insiders & institutionals hold more shares of CRVL or CHE?

Which has more risk & volatility, CRVL or CHE?

Does the media prefer CRVL or CHE?

Which has preferable earnings and valuation, CRVL or CHE?

Is CRVL or CHE more profitable?

Do analysts prefer CRVL or CHE?

Summary

How does CorVel compare to Pediatrix Medical Group?

Do analysts recommend CRVL or MD?

Is CRVL or MD more profitable?

Do institutionals & insiders believe in CRVL or MD?

Which has stronger valuation and earnings, CRVL or MD?

Does the media refer more to CRVL or MD?

Which has more risk & volatility, CRVL or MD?

Summary

How does CorVel compare to AMN Healthcare Services?

Which has higher valuation & earnings, CRVL or AMN?

Does the media prefer CRVL or AMN?

Do analysts rate CRVL or AMN?

Which has more risk & volatility, CRVL or AMN?

Is CRVL or AMN more profitable?

Do institutionals and insiders hold more shares of CRVL or AMN?

Summary

How does CorVel compare to Cross Country Healthcare?

Is CCRN or CRVL more profitable?

Does the media refer more to CCRN or CRVL?

Do analysts rate CCRN or CRVL?

Which has more volatility & risk, CCRN or CRVL?

Which has higher earnings and valuation, CCRN or CRVL?

Do institutionals & insiders have more ownership in CCRN or CRVL?

Summary

How does CorVel compare to Labcorp?

Is LH or CRVL more profitable?

Do analysts prefer LH or CRVL?

Do institutionals and insiders hold more shares of LH or CRVL?

Does the media refer more to LH or CRVL?

Which has higher valuation and earnings, LH or CRVL?

Which has more risk and volatility, LH or CRVL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRVL vs. The Competition

CorVel Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools